Cargando…

Urine Proteomic Study in OAB Patients—Preliminary Report

Overactive bladder (OAB) is defined by International Urogynecological Association (IUGA)/ International Continence Society (ICS) as urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection (UTI) or other o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Futyma, Konrad, Nowakowski, Łukasz, Ziętek-Strobl, Alicja, Kamińska, Aleksandra, Taoussi, Nadia, Rechberger, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290998/ https://www.ncbi.nlm.nih.gov/pubmed/32397227 http://dx.doi.org/10.3390/jcm9051389

Ejemplares similares

Urogynaecological Symptoms among Oncological Survivors and Impact of Oncological Treatment on Pelvic Floor Disorders and Lower Urinary Tract Symptoms. A Six-Month Follow-Up Study
por: Ziętek-Strobl, Alicja, et al.
Publicado: (2020)

Urinary retention in female OAB after intravesical Botox injection: who is really at risk?
por: Miotla, Pawel, et al.
Publicado: (2016)

Effectiveness of botulinum toxin injection in the treatment of de novo OAB symptoms following midurethral sling surgery
por: Miotla, Pawel, et al.
Publicado: (2015)

Quality of Sexual Life after Native Tissue versus Polypropylene Mesh Augmented Pelvic Floor Reconstructive Surgery
por: Kamińska, Aleksandra, et al.
Publicado: (2021)

Reliability of the Polish Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) and Assessment of Sexual Function before and after Pelvic Organ Prolapse Reconstructive Surgery—A Prospective Study
por: Kamińska, Aleksandra, et al.
Publicado: (2021)

Candida lusitaniae – a case report of an intraperitoneal infection
por: Wawrysiuk, Sara, et al.
Publicado: (2018)

Decrease in the Ratio proBDNF/BDNF in the Urine of Aging Female Patients with OAB
por: Covarrubias, Claudia, et al.
Publicado: (2023)

A classification of complications in urogynecology
por: Gałczyński, Krzysztof, et al.
Publicado: (2014)

Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume
por: Kuno, Takahira, et al.
Publicado: (2023)

Urine Nerve Growth Factor May Not Be Useful as a Biomarker of Overactive Bladder in Patients with Pelvic Organ Prolapse
por: Jankiewicz, Katarzyna, et al.
Publicado: (2022)

Transobturator midurethral sling: What should patients expect after surgery?
por: Rechberger, Tomasz, et al.
Publicado: (2017)

Real-Time Documentation of the Effect of Onabotulinumtoxin A Detrusor Injection in OAB Patients—Preliminary Results
por: Schulte-Baukloh, Heinrich, et al.
Publicado: (2022)

Does Pharmacological Treatment Reduce the Incidence of Lower Urinary Tract Symptoms (LUTS) after Transobturator Sling?
por: Rechberger, Tomasz, et al.
Publicado: (2019)

Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?
por: Frankel, Jeffrey, et al.
Publicado: (2023)

AB33. Botox: the novel therapy for OAB
por: Deng, Donna
Publicado: (2014)

Platelet-Rich Plasma as Adjuvant Therapy for Recurrent Vesicovaginal Fistula: A Prospective Case Series
por: Streit-Ciećkiewicz, Dominika, et al.
Publicado: (2019)

The emperor has no clothes: OAB can be cured surgically
por: Petros, Peter
Publicado: (2022)

Expression of genes encoding extracellular matrix proteins: A macroarray study
por: FUTYMA, KONRAD, et al.
Publicado: (2014)

Development of a core set of outcome measures for OAB treatment
por: Foust-Wright, Caroline, et al.
Publicado: (2017)

Can Intradetrusor OnabotulinumtoxinA Injections Alter Heart Function in Patients with Cardiac Arrhythmia?
por: Miotla, Pawel, et al.
Publicado: (2018)

Brain penetration of the OAB drug trospium chloride is not increased in aged mice
por: Kranz, Jasmin, et al.
Publicado: (2011)

Quo Vadis Botulinum Toxin: Normative Constraints and Quality of Life for Patients With Idiopathic OAB?
por: Mühlstädt, Sandra, et al.
Publicado: (2018)

OAB-045: COVID-19 vaccine responsiveness in patients with Multiple Myeloma and Waldenström Macroglobulinemia
por: Branagan, Andrew, et al.
Publicado: (2021)

Do we need more patient‐friendly treatment options for overactive bladder (OAB)?
por: Gerig, Nel, et al.
Publicado: (2021)

An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation
por: Futyma, Konrad, et al.
Publicado: (2015)

Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review
por: Khizer, Zara, et al.
Publicado: (2021)

OAB-046: COVID-19 infection in multiple myeloma patients – retrospective analysis of 371 Czech patients
por: Radocha, Jakub, et al.
Publicado: (2021)

Transurethral Microwave Thermotherapy (TUMT) in the Treatment of Benign Prostatic Hyperplasia: A Preliminary Report
por: Ziętek, Roger J., et al.
Publicado: (2021)

Tolterodine extended release in the treatment of male oab/storage luts: a systematic review
por: Gacci, Mauro, et al.
Publicado: (2014)

The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population
por: Lai, H. Henry, et al.
Publicado: (2016)

De novo OAB After ATOMS: An Underestimated Problem or a Rare Side Effect?
por: Schönburg, Sandra, et al.
Publicado: (2019)

Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder
por: Desroziers, Katia, et al.
Publicado: (2013)

Psychometric Properties of the Korean Version of the Overactive Bladder Questionnaire (OAB-q) in a Korean Population
por: Oh, Seung-June, et al.
Publicado: (2012)

OAB score: A clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study
por: Arribillaga, Leandro Cristian, et al.
Publicado: (2018)

Personalised 3D-Printed Mucoadhesive Gastroretentive Hydrophilic Matrices for Managing Overactive Bladder (OAB)
por: Khizer, Zara, et al.
Publicado: (2023)

Efficacy of Fractional CO(2) Laser Treatment for Genitourinary Syndrome of Menopause in Short-Term Evaluation—Preliminary Study
por: Woźniak, Andrzej, et al.
Publicado: (2023)

Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome management
por: Turell, Wendy, et al.
Publicado: (2020)

Influence of current state of executive function and working memory on adherence to antimuscarinic therapy in older women with OAB
por: Kosilov, Kirill, et al.
Publicado: (2019)

Do Older Adults with Overactive Bladder Demonstrate Impaired Executive Function Compared to Their Peers Without OAB?
por: Gibson, William, et al.
Publicado: (2020)

Defining urge as an uncontrolled micturition explains pathogenesis, informs cure and helps solve the burgeoning OAB crisis
por: Petros, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4s4775tj0j16gt7ldk7ls4cmkh